Literature DB >> 17050612

Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I.

Sharookh B Kapadia1, Heidi Barth, Thomas Baumert, Jane A McKeating, Francis V Chisari.   

Abstract

In the past several years, a number of cellular proteins have been identified as candidate entry receptors for hepatitis C virus (HCV) by using surrogate models of HCV infection. Among these, the tetraspanin CD81 and scavenger receptor B type I (SR-BI), both of which localize to specialized plasma membrane domains enriched in cholesterol, have been suggested to be key players in HCV entry. In the current study, we used a recently developed in vitro HCV infection system to demonstrate that both CD81 and SR-BI are required for authentic HCV infection in vitro, that they function cooperatively to initiate HCV infection, and that CD81-mediated HCV entry is, in part, dependent on membrane cholesterol.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17050612      PMCID: PMC1797271          DOI: 10.1128/JVI.01134-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  92 in total

Review 1.  Replication of hepatitis C virus.

Authors:  R Bartenschlager; V Lohmann
Journal:  J Gen Virol       Date:  2000-07       Impact factor: 3.891

2.  Plasma membrane rafts play a critical role in HIV-1 assembly and release.

Authors:  A Ono; E O Freed
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

Review 3.  Role of lipid rafts in virus assembly and budding.

Authors:  Debi P Nayak; Subrata Barman
Journal:  Adv Virus Res       Date:  2002       Impact factor: 9.937

4.  Genetic analysis of sequences in the 3' nontranslated region of hepatitis C virus that are important for RNA replication.

Authors:  Peter Friebe; Ralf Bartenschlager
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

Review 5.  Cellular and physiological roles of SR-BI, a lipoprotein receptor which mediates selective lipid uptake.

Authors:  B L Trigatti; A Rigotti; A Braun
Journal:  Biochim Biophys Acta       Date:  2000-12-15

6.  Hepatitis C virus envelope protein E2 binds to CD81 of tamarins.

Authors:  T Allander; X Forns; S U Emerson; R H Purcell; J Bukh
Journal:  Virology       Date:  2000-11-25       Impact factor: 3.616

7.  Determinants of hepatitis C translational initiation in vitro, in cultured cells and mice.

Authors:  Anton P McCaffrey; Kazuo Ohashi; Leonard Meuse; Shiliang Shen; Alissa M Lancaster; Peter J Lukavsky; Peter Sarnow; Mark A Kay
Journal:  Mol Ther       Date:  2002-06       Impact factor: 11.454

8.  Characterization of low- and very-low-density hepatitis C virus RNA-containing particles.

Authors:  P André; F Komurian-Pradel; S Deforges; M Perret; J L Berland; M Sodoyer; S Pol; C Bréchot; G Paranhos-Baccalà; V Lotteau
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

9.  The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

Authors:  Elisa Scarselli; Helenia Ansuini; Raffaele Cerino; Rosa Maria Roccasecca; Stefano Acali; Gessica Filocamo; Cinzia Traboni; Alfredo Nicosia; Riccardo Cortese; Alessandra Vitelli
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

10.  Restriction of lentivirus in monkeys.

Authors:  Caroline Besnier; Yasuhiro Takeuchi; Greg Towers
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-01       Impact factor: 11.205

View more
  128 in total

1.  Enhanced hepatitis C virus genome replication and lipid accumulation mediated by inhibition of AMP-activated protein kinase.

Authors:  Jamel Mankouri; Philip R Tedbury; Sarah Gretton; Mair E Hughes; Stephen D C Griffin; Mark L Dallas; Kevin A Green; D Grahame Hardie; Chris Peers; Mark Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

2.  Hepatitis C virus infection of human T lymphocytes is mediated by CD5.

Authors:  Mohammed A Sarhan; Tram N Q Pham; Annie Y Chen; Tomasz I Michalak
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

Review 3.  Unique ties between hepatitis C virus replication and intracellular lipids.

Authors:  Eva Herker; Melanie Ott
Journal:  Trends Endocrinol Metab       Date:  2011-04-15       Impact factor: 12.015

4.  Identification of alpha interferon-induced envelope mutations of hepatitis C virus in vitro associated with increased viral fitness and interferon resistance.

Authors:  Stéphanie B N Serre; Henrik B Krarup; Jens Bukh; Judith M Gottwein
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

5.  MicroRNA-185-5p mediates regulation of SREBP2 expression by hepatitis C virus core protein.

Authors:  Min Li; Qi Wang; Shun-Ai Liu; Jin-Qian Zhang; Wei Ju; Min Quan; Sheng-Hu Feng; Jin-Ling Dong; Ping Gao; Jun Cheng
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

6.  Differential effects of hepatitis C virus JFH1 on human myeloid and plasmacytoid dendritic cells.

Authors:  Hua Liang; Rodney S Russell; Nicole L Yonkers; David McDonald; Benigno Rodriguez; Clifford V Harding; Donald D Anthony
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

Review 7.  The roles of tetraspanins in HIV-1 replication.

Authors:  Markus Thali
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

8.  West Nile virus entry requires cholesterol-rich membrane microdomains and is independent of alphavbeta3 integrin.

Authors:  Guruprasad R Medigeshi; Alec J Hirsch; Daniel N Streblow; Janko Nikolich-Zugich; Jay A Nelson
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

9.  Role of cholesterol pathways in norovirus replication.

Authors:  Kyeong-Ok Chang
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

Review 10.  Sequence diversity of hepatitis C virus: implications for immune control and therapy.

Authors:  Joerg Timm; Michael Roggendorf
Journal:  World J Gastroenterol       Date:  2007-09-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.